CB --The Xience V everolimus-eluting stent and Cypher sirolimus-eluting stents provide comparable clinical outcomes out to two years, based on results of ISAR-TEST 4 trial presented as a late-breaking clinical trial Sept. 24 at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference.
